In CRC, the expression of ADAR1 and HER3 increased while PREX1 levels decreased with stage progression from I to IV (Figure 4E); thus, we observed a positive correlation between ADAR1 and HER3 and a negative correlation between PREX1 and the tumour stage of CRC (Figure 4F). Here, ERBB3 is linked to colorectal carcinoma.